10-52768506-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378373.1(MBL2):​c.378C>G​(p.Leu126Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.816 in 1,551,782 control chromosomes in the GnomAD database, including 518,861 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 46570 hom., cov: 32)
Exomes 𝑓: 0.82 ( 472291 hom. )

Consequence

MBL2
NM_001378373.1 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.68

Publications

45 publications found
Variant links:
Genes affected
MBL2 (HGNC:6922): (mannose binding lectin 2) This gene encodes the soluble mannose-binding lectin or mannose-binding protein found in serum. The protein encoded belongs to the collectin family and is an important element in the innate immune system. The protein recognizes and binds to mannose and N-acetylglucosamine on many microorganisms, including bacteria, yeast, and viruses including influenza virus, HIV and SARS-CoV. This binding activates the classical complement pathway. Deficiencies of this gene have been associated with susceptibility to autoimmune and infectious diseases. [provided by RefSeq, Jun 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-52768506-G-C is Benign according to our data. Variant chr10-52768506-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 300148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.68 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.831 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MBL2NM_001378373.1 linkc.378C>G p.Leu126Leu synonymous_variant Exon 5 of 5 ENST00000674931.1 NP_001365302.1
MBL2NM_000242.3 linkc.378C>G p.Leu126Leu synonymous_variant Exon 4 of 4 NP_000233.1
MBL2NM_001378374.1 linkc.378C>G p.Leu126Leu synonymous_variant Exon 5 of 5 NP_001365303.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MBL2ENST00000674931.1 linkc.378C>G p.Leu126Leu synonymous_variant Exon 5 of 5 NM_001378373.1 ENSP00000502789.1
MBL2ENST00000373968.3 linkc.378C>G p.Leu126Leu synonymous_variant Exon 4 of 4 1 ENSP00000363079.3
MBL2ENST00000675947.1 linkc.378C>G p.Leu126Leu synonymous_variant Exon 5 of 5 ENSP00000502615.1

Frequencies

GnomAD3 genomes
AF:
0.778
AC:
118106
AN:
151736
Hom.:
46525
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.678
Gnomad AMI
AF:
0.948
Gnomad AMR
AF:
0.843
Gnomad ASJ
AF:
0.857
Gnomad EAS
AF:
0.765
Gnomad SAS
AF:
0.756
Gnomad FIN
AF:
0.797
Gnomad MID
AF:
0.756
Gnomad NFE
AF:
0.818
Gnomad OTH
AF:
0.781
GnomAD2 exomes
AF:
0.807
AC:
163672
AN:
202776
AF XY:
0.806
show subpopulations
Gnomad AFR exome
AF:
0.665
Gnomad AMR exome
AF:
0.892
Gnomad ASJ exome
AF:
0.870
Gnomad EAS exome
AF:
0.755
Gnomad FIN exome
AF:
0.795
Gnomad NFE exome
AF:
0.822
Gnomad OTH exome
AF:
0.822
GnomAD4 exome
AF:
0.820
AC:
1147933
AN:
1399926
Hom.:
472291
Cov.:
35
AF XY:
0.818
AC XY:
565768
AN XY:
691242
show subpopulations
African (AFR)
AF:
0.671
AC:
21080
AN:
31408
American (AMR)
AF:
0.882
AC:
32341
AN:
36676
Ashkenazi Jewish (ASJ)
AF:
0.863
AC:
18923
AN:
21934
East Asian (EAS)
AF:
0.793
AC:
31125
AN:
39264
South Asian (SAS)
AF:
0.762
AC:
56818
AN:
74582
European-Finnish (FIN)
AF:
0.799
AC:
40862
AN:
51120
Middle Eastern (MID)
AF:
0.754
AC:
4104
AN:
5440
European-Non Finnish (NFE)
AF:
0.828
AC:
895811
AN:
1081778
Other (OTH)
AF:
0.812
AC:
46869
AN:
57724
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
8919
17838
26758
35677
44596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20788
41576
62364
83152
103940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.778
AC:
118203
AN:
151856
Hom.:
46570
Cov.:
32
AF XY:
0.780
AC XY:
57877
AN XY:
74220
show subpopulations
African (AFR)
AF:
0.678
AC:
27977
AN:
41250
American (AMR)
AF:
0.844
AC:
12882
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.857
AC:
2962
AN:
3456
East Asian (EAS)
AF:
0.767
AC:
3964
AN:
5170
South Asian (SAS)
AF:
0.754
AC:
3639
AN:
4824
European-Finnish (FIN)
AF:
0.797
AC:
8424
AN:
10574
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.818
AC:
55613
AN:
67998
Other (OTH)
AF:
0.783
AC:
1649
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1319
2637
3956
5274
6593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.798
Hom.:
8696
Bravo
AF:
0.780
Asia WGS
AF:
0.782
AC:
2719
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mannose-binding lectin deficiency Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.73
DANN
Benign
0.80
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs930507; hg19: chr10-54528266; COSMIC: COSV107495043; API